PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'Harvard Medical School, Boston, Massachusetts, USA.\', \'Division of Clinical Informatics, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\', \'Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1382
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33532847
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all